New Petition Targets Dartmouth Patent Covering ‘Isolated’ Nicotinamide
ALEXANDRIA, Va. — A research organization on Feb. 1 told the Patent Trial and Appeal Board that it should cancel a patent that recites isolated nicotinamide riboside kinase (Nrk) nucleic acid...To view the full article, register now.
Already a subscriber? Click here to view full article